var data={"title":"Infectious folliculitis","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Infectious folliculitis</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/contributors\" class=\"contributor contributor_credentials\">Jeremy D Jackson, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/contributors\" class=\"contributor contributor_credentials\">Ted Rosen, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/contributors\" class=\"contributor contributor_credentials\">Abena O Ofori, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Feb 14, 2018.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H604478843\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Folliculitis refers to inflammation of the superficial or deep portion of the hair follicle. The classic clinical findings of superficial folliculitis are follicular pustules and follicular erythematous papules on hair-bearing skin. Nodules are a feature of deep follicular inflammation.</p><p>Folliculitis may be infectious or, less frequently, noninfectious. Various bacteria, fungi, viruses, and parasites are causes of infectious folliculitis.</p><p>The etiology, clinical manifestations, diagnosis, and management of infectious folliculitis will be reviewed here. Noninfectious causes, such as human immunodeficiency virus (HIV)-associated eosinophilic folliculitis and drug-induced folliculitis, are reviewed separately. (See <a href=\"topic.htm?path=hiv-associated-eosinophilic-folliculitis\" class=\"medical medical_review\">&quot;HIV-associated eosinophilic folliculitis&quot;</a> and <a href=\"topic.htm?path=acneiform-eruption-secondary-to-epidermal-growth-factor-receptor-egfr-inhibitors\" class=\"medical medical_review\">&quot;Acneiform eruption secondary to epidermal growth factor receptor (EGFR) inhibitors&quot;</a> and <a href=\"topic.htm?path=approach-to-the-patient-with-pustular-skin-lesions\" class=\"medical medical_review\">&quot;Approach to the patient with pustular skin lesions&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H604478849\"><span class=\"h1\">BACTERIAL FOLLICULITIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Bacterial infection is the most common cause of infectious folliculitis.</p><p class=\"headingAnchor\" id=\"H1548859911\"><span class=\"h2\">Etiology and risk factors</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Frequent causes of bacterial folliculitis include <em>Staphylococcus aureus</em> and gram-negative bacteria.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong><em>Staphylococcus aureus </em></strong>&ndash; <em>S. aureus</em>, a gram-positive bacterium, is the most common cause of bacterial folliculitis. &quot;Impetigo of Bockhart&quot; and &quot;Bockhart impetigo&quot; are alternative terms for superficial staphylococcal folliculitis.</p><p/><p class=\"bulletIndent1\">Both methicillin-sensitive and methicillin-resistant <em>S. aureus</em> (MRSA) can cause folliculitis. Folliculitis is among the infections contributing to the increasing prevalence of community-acquired MRSA infections [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/1\" class=\"abstract_t\">1</a>]. (See <a href=\"topic.htm?path=methicillin-resistant-staphylococcus-aureus-mrsa-in-adults-epidemiology\" class=\"medical medical_review\">&quot;Methicillin-resistant Staphylococcus aureus (MRSA) in adults: Epidemiology&quot;</a> and <a href=\"topic.htm?path=methicillin-resistant-staphylococcus-aureus-infections-in-children-epidemiology-and-clinical-spectrum\" class=\"medical medical_review\">&quot;Methicillin-resistant Staphylococcus aureus infections in children: Epidemiology and clinical spectrum&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Gram-negative folliculitis</strong> &ndash; <em>Pseudomonas aeruginosa </em>is a gram-negative bacterium and the cause of &quot;hot tub folliculitis,&quot; a form of folliculitis attributed to contact with water contaminated with <em>Pseudomonas </em>as a result of inadequate chlorine, bromine, or pH levels in whirlpools, hot tubs, or swimming pools [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/2\" class=\"abstract_t\">2</a>]. Bathing with contaminated sponges or nylon towels and use of contaminated rubber gloves are additional potential modes of acquisition [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/3-5\" class=\"abstract_t\">3-5</a>]. (See <a href=\"topic.htm?path=pseudomonas-aeruginosa-skin-and-soft-tissue-infections#H9\" class=\"medical medical_review\">&quot;Pseudomonas aeruginosa skin and soft tissue infections&quot;, section on 'Hot tub-associated eruptions'</a>.)</p><p/><p class=\"bulletIndent1\">Other organisms responsible for gram-negative folliculitis include <em>Klebsiella, Enterobacter,</em> and<em> Proteus </em>species. These bacteria are common causes of gram-negative folliculitis associated with long-term treatment with oral antibiotics (eg, tetracyclines) for acne vulgaris [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/6\" class=\"abstract_t\">6</a>]. <em>Aeromonas hydrophila</em>, another gram-negative organism, can cause folliculitis after recreational water exposure [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/7\" class=\"abstract_t\">7</a>]. (See <a href=\"topic.htm?path=pathogenesis-clinical-manifestations-and-diagnosis-of-acne-vulgaris#H17\" class=\"medical medical_review\">&quot;Pathogenesis, clinical manifestations, and diagnosis of acne vulgaris&quot;, section on 'Gram-negative folliculitis'</a>.)</p><p/><p>Bacterial folliculitis can occur in infants, children, or adults. Factors that may increase risk include [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/8\" class=\"abstract_t\">8</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Nasal carriage of <em>S. aureus</em></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Occlusion of hair follicles</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hyperhidrosis</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Scratching secondary to pruritic skin disease (eg, atopic dermatitis)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Prolonged application of topical corticosteroids</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Long-term oral antibiotic therapy for acne</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Shaving against the direction of hair growth</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Exposure to hot tubs or heated swimming pools</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Male sex (for gram-negative folliculitis associated with oral antibiotic therapy for acne vulgaris) [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/6\" class=\"abstract_t\">6</a>]</p><p/><p class=\"headingAnchor\" id=\"H604478862\"><span class=\"h2\">Clinical manifestations</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The classic clinical findings in bacterial folliculitis are follicular pustules and follicular erythematous papules (<a href=\"image.htm?imageKey=DERM%2F103499%7EDERM%2F103500%7EDERM%2F62930%7EDERM%2F50187\" class=\"graphic graphic_picture graphicRef103499 graphicRef103500 graphicRef62930 graphicRef50187 \">picture 1A-D</a>). Pruritus is the most common symptom associated with folliculitis. Patients may also experience painful pustules.</p><p>Folliculitis can occur on any hair-bearing area; however, certain etiologies often correlate with particular distributions [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/8\" class=\"abstract_t\">8</a>]. <em>S. aureus </em>folliculitis is most common on the scalp and face [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/9\" class=\"abstract_t\">9</a>]. Other common sites include the upper trunk, buttocks, and legs, as well as the axillae in infants and children [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/8\" class=\"abstract_t\">8</a>]. Community-acquired MRSA folliculitis may be more likely to occur on the chest, flanks, scrotum, and periumbilical region than methicillin-sensitive <em>S. aureus</em> infections [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/1\" class=\"abstract_t\">1</a>].</p><p>Folliculitis barbae (also known as sycosis barbae) is a bacterial folliculitis involving deep portions of the hair follicles in the beard areas of the face and neck. <em>S. aureus </em>is a frequent causative organism. Folliculitis barbae is often characterized by tender pustules within erythematous plaques involving multiple hair follicles [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/8,9\" class=\"abstract_t\">8,9</a>].</p><p>&quot;Hot tub folliculitis&quot; induced by <em>P. aeruginosa </em>presents with pruritic follicular macules, papules, or pustules (<a href=\"image.htm?imageKey=ID%2F98255%7EID%2F98256\" class=\"graphic graphic_picture graphicRef98255 graphicRef98256 \">picture 2A-B</a>). The eruption appears 8 to 48 hours after exposure and primarily occurs on the trunk and buttocks in the distribution of the wet bathing suit or other areas exposed to contaminated water [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/2\" class=\"abstract_t\">2</a>]. (See <a href=\"topic.htm?path=pseudomonas-aeruginosa-skin-and-soft-tissue-infections#H9\" class=\"medical medical_review\">&quot;Pseudomonas aeruginosa skin and soft tissue infections&quot;, section on 'Hot tub-associated eruptions'</a>.)</p><p>Gram-negative folliculitis due to <em>Klebsiella, Enterobacter, </em>or <em>Proteus</em> and associated with long-term oral antibiotic treatment for acne vulgaris typically occurs on the face, most commonly in the perinasal region.</p><p>Deep infection of the hair follicle can lead to development of a furuncle (or &quot;boil&quot;). Multiple furuncles can coalesce to form carbuncles. In most cases, <em>S. aureus</em> is the cause [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/10\" class=\"abstract_t\">10</a>]. Furuncles and carbuncles are reviewed separately. (See <a href=\"topic.htm?path=cellulitis-and-skin-abscess-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Cellulitis and skin abscess: Clinical manifestations and diagnosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H604478868\"><span class=\"h2\">Diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Bacterial folliculitis is usually diagnosed by means of the patient history and physical examination. The diagnosis should be suspected in patients with follicularly-based papules or pustules who lack additional features suggestive of another follicular or inflammatory skin disorder. (See <a href=\"#H604478874\" class=\"local\">'Differential diagnosis'</a> below.)</p><p>The patient history may offer clues to the etiology of folliculitis. For example, <em>Pseudomonas</em> folliculitis should be suspected in patients reporting an acute eruption following exposure to hot tubs or heated swimming pools, and gram-negative folliculitis should be considered in patients with a recent history of prolonged oral antibiotic therapy for acne. Immunosuppressed patients may have increased risk for fungal or viral folliculitis, warranting stronger consideration of these disorders in the differential diagnosis of bacterial folliculitis. (See <a href=\"#H604478886\" class=\"local\">'Fungal folliculitis'</a> below and <a href=\"#H604478922\" class=\"local\">'Viral folliculitis'</a> below.)</p><p>Recognition of the distribution of folliculitis may also be useful. Folliculitis limited to the scalp <span class=\"nowrap\">and/or</span> face is often secondary to <em>S. aureus</em>. <em>Pseudomonas</em> folliculitis typically occurs on areas of skin exposed to contaminated water.</p><p>Further work-up is primarily reserved for patients with an unclear diagnosis or treatment-resistant disease. A Gram stain and culture of the contents of a pustule can confirm the presence of infection and identify the causative organism. Infrequently, a skin biopsy is necessary to differentiate folliculitis from other skin conditions. Histopathologic examination of bacterial folliculitis shows neutrophils infiltrating a hair follicle (<a href=\"image.htm?imageKey=DERM%2F103501\" class=\"graphic graphic_picture graphicRef103501 \">picture 3</a>) [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/9\" class=\"abstract_t\">9</a>].</p><p class=\"headingAnchor\" id=\"H604478874\"><span class=\"h2\">Differential diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The differential diagnosis of infectious folliculitis includes the various forms of infectious folliculitis (eg, bacterial, fungal, viral, <em>Demodex</em>) and other papular, pustular, or follicular eruptions.</p><p>Common eruptions on the face or scalp that may be confused with infectious folliculitis include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Acne vulgaris</strong> &ndash; The characteristic clinical features of acne vulgaris are open and closed comedones and inflammatory papules and pustules on the face, chest, shoulders, or back (<a href=\"image.htm?imageKey=DERM%2F70809\" class=\"graphic graphic_picture graphicRef70809 \">picture 4</a>). The presence of comedones and a lack of pruritus are more consistent with acne vulgaris than folliculitis. (See <a href=\"topic.htm?path=pathogenesis-clinical-manifestations-and-diagnosis-of-acne-vulgaris\" class=\"medical medical_review\">&quot;Pathogenesis, clinical manifestations, and diagnosis of acne vulgaris&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Papulopustular rosacea</strong> &ndash; Papulopustular rosacea primarily affects adults and presents with pustules and erythematous papules on the central face (<a href=\"image.htm?imageKey=DERM%2F67890\" class=\"graphic graphic_picture graphicRef67890 \">picture 5</a>). Exacerbating factors such as alcohol, spicy foods, sun exposure, and temperature changes are common. (See <a href=\"topic.htm?path=rosacea-pathogenesis-clinical-features-and-diagnosis\" class=\"medical medical_review\">&quot;Rosacea: Pathogenesis, clinical features, and diagnosis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Perioral (periorificial) dermatitis</strong> &ndash; Perioral dermatitis presents with small erythematous papules around the mouth, nose, or periorbital areas (<a href=\"image.htm?imageKey=DERM%2F64577\" class=\"graphic graphic_picture graphicRef64577 \">picture 6</a>). There may be associated mild scale. Perioral dermatitis is most common in young women. (See <a href=\"topic.htm?path=perioral-periorificial-dermatitis\" class=\"medical medical_review\">&quot;Perioral (periorificial) dermatitis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Acne keloidalis nuchae</strong> &ndash; Acne keloidalis nuchae is a chronic, scarring folliculitis that primarily affects males of African descent. Papules, pustules, and keloid-like papules and plaques develop on the posterior scalp (<a href=\"image.htm?imageKey=DERM%2F97993\" class=\"graphic graphic_picture graphicRef97993 \">picture 7</a>). (See <a href=\"topic.htm?path=acne-keloidalis-nuchae\" class=\"medical medical_review\">&quot;Acne keloidalis nuchae&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Pseudofolliculitis barbae</strong> &ndash; Pseudofolliculitis barbae is an inflammatory reaction to hair penetrating interfollicular skin. Patients develop inflamed papules and pustules following hair removal in the beard area of the face or neck (<a href=\"image.htm?imageKey=PC%2F69365\" class=\"graphic graphic_picture graphicRef69365 \">picture 8</a>). Pseudofolliculitis barbae is most common in patients of African descent. (See <a href=\"topic.htm?path=pseudofolliculitis-barbae\" class=\"medical medical_review\">&quot;Pseudofolliculitis barbae&quot;</a>.)</p><p/><p>Common eruptions in the differential diagnosis that most frequently affect the trunk or extremities include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Drug-induced folliculitis</strong> &ndash; A monomorphic papulopustular eruption on the trunk and arms known as &quot;steroid folliculitis&quot; or &quot;steroid acne&quot; may occur after administration of systemic glucocorticoids (<a href=\"image.htm?imageKey=DERM%2F86994%7EDERM%2F86995\" class=\"graphic graphic_picture graphicRef86994 graphicRef86995 \">picture 9A-B</a>) [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/11\" class=\"abstract_t\">11</a>]. Other drugs that may cause folliculitis-like eruptions include <a href=\"topic.htm?path=phenytoin-drug-information\" class=\"drug drug_general\">phenytoin</a>, <a href=\"topic.htm?path=lithium-drug-information\" class=\"drug drug_general\">lithium</a>, <a href=\"topic.htm?path=isoniazid-drug-information\" class=\"drug drug_general\">isoniazid</a>, <a href=\"topic.htm?path=cyclosporine-ciclosporin-drug-information\" class=\"drug drug_general\">cyclosporine</a>, halogens, and epidermal growth factor receptor inhibitors (<a href=\"image.htm?imageKey=PC%2F55753\" class=\"graphic graphic_picture graphicRef55753 \">picture 10</a>). (See <a href=\"topic.htm?path=pathogenesis-clinical-manifestations-and-diagnosis-of-acne-vulgaris#H28\" class=\"medical medical_review\">&quot;Pathogenesis, clinical manifestations, and diagnosis of acne vulgaris&quot;, section on 'Drug-induced acne'</a> and <a href=\"topic.htm?path=acneiform-eruption-secondary-to-epidermal-growth-factor-receptor-egfr-inhibitors\" class=\"medical medical_review\">&quot;Acneiform eruption secondary to epidermal growth factor receptor (EGFR) inhibitors&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Keratosis pilaris</strong> &ndash; Keratosis pilaris is a common disorder of follicular keratinization that presents with asymptomatic, keratotic follicular papules on the upper arms, face, thighs, and buttocks (<a href=\"image.htm?imageKey=DERM%2F60786\" class=\"graphic graphic_picture graphicRef60786 \">picture 11</a>). Keratosis pilaris is most commonly seen in children and young adults. (See <a href=\"topic.htm?path=keratosis-pilaris\" class=\"medical medical_review\">&quot;Keratosis pilaris&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Hidradenitis suppurativa</strong> &ndash; Hidradenitis suppurativa is a chronic inflammatory skin disorder characterized by the development of inflamed nodules, abscesses, and sinus tracts (<a href=\"image.htm?imageKey=DERM%2F90465\" class=\"graphic graphic_picture graphicRef90465 \">picture 12</a>). Involvement occurs primarily in the axillary, mammary, and inguinal areas. (See <a href=\"topic.htm?path=hidradenitis-suppurativa-pathogenesis-clinical-features-and-diagnosis\" class=\"medical medical_review\">&quot;Hidradenitis suppurativa: Pathogenesis, clinical features, and diagnosis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Scabies</strong> &ndash; <em>Sarcoptes scabiei</em> infestation often presents with intensely pruritic pustules and papules in the axillae, inguinal areas, interdigital web spaces, waistline, and volar wrists (<a href=\"image.htm?imageKey=DERM%2F75169\" class=\"graphic graphic_picture graphicRef75169 \">picture 13</a>). (See <a href=\"topic.htm?path=scabies-epidemiology-clinical-features-and-diagnosis\" class=\"medical medical_review\">&quot;Scabies: Epidemiology, clinical features, and diagnosis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Grover's disease (transient acantholytic dermatosis)</strong> &ndash; Grover's disease most commonly presents as erythematous papules on the chest and back in men in their fifth decade or older (<a href=\"image.htm?imageKey=PC%2F76504\" class=\"graphic graphic_picture graphicRef76504 \">picture 14</a>). Histopathology demonstrates focal acantholytic dyskeratosis that is not centered upon hair follicles. (See <a href=\"topic.htm?path=grovers-disease-transient-and-persistent-acantholytic-dermatosis\" class=\"medical medical_review\">&quot;Grover's disease (transient and persistent acantholytic dermatosis)&quot;</a>.)</p><p/><p>Other disorders in the differential diagnosis include irritant folliculitis, actinic folliculitis, and perforating folliculitis.</p><p class=\"headingAnchor\" id=\"H604478880\"><span class=\"h2\">Treatment</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The etiology of folliculitis influences the approach to treatment. Because <em>S. aureus</em> folliculitis is the most common form of bacterial folliculitis, patients are often empirically treated for this infection provided the history and physical examination do not suggest another type of folliculitis. An evaluation to confirm the diagnosis is prudent when patients fail to respond to treatment. (See <a href=\"#H604478868\" class=\"local\">'Diagnosis'</a> above.)</p><p class=\"headingAnchor\" id=\"H19981424\"><span class=\"h3\">Staphylococcal folliculitis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Treatment of staphylococcal folliculitis is not always necessary; mild folliculitis with few pustules often resolves spontaneously. Patients with numerous papules or pustules or with involvement of more than one body area are good candidates for medical treatment. Folliculitis that does not resolve spontaneously after several weeks also should be treated.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Medical therapy</strong> &ndash; Topical antibiotic therapy is sufficient for many cases of bacterial folliculitis [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/12\" class=\"abstract_t\">12</a>]. Our preferred first-line agents are topical <a href=\"topic.htm?path=mupirocin-drug-information\" class=\"drug drug_general\">mupirocin</a> and topical <a href=\"topic.htm?path=clindamycin-drug-information\" class=\"drug drug_general\">clindamycin</a> [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/12\" class=\"abstract_t\">12</a>]. Topical <a href=\"topic.htm?path=fusidic-acid-united-states-not-available-drug-information\" class=\"drug drug_general\">fusidic acid</a> is an additional first-line treatment option; however, increasing resistance of <em>S. aureus </em>to fusidic acid has been observed in areas where fusidic acid use is common, and the drug is not available in the United States [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/13\" class=\"abstract_t\">13</a>]. Topical <a href=\"topic.htm?path=erythromycin-drug-information\" class=\"drug drug_general\">erythromycin</a> may also be effective; however, topical erythromycin has fallen out of favor as a first-line treatment in many locations due to increasing prevalence of erythromycin-resistance and community-acquired MRSA infections [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/1\" class=\"abstract_t\">1</a>].</p><p/><p class=\"bulletIndent1\">Patients with extensive skin involvement, patients with staphylococcal folliculitis that is recurrent or refractory after topical therapy, and patients with folliculitis barbae are usually treated with oral antibiotics. A 7- to 10-day course is usually sufficient. Due to the high frequency of resistance to penicillin, other beta-lactam antibiotics such as <a href=\"topic.htm?path=dicloxacillin-drug-information\" class=\"drug drug_general\">dicloxacillin</a> (250 to 500 mg four times per day) or <a href=\"topic.htm?path=cephalexin-drug-information\" class=\"drug drug_general\">cephalexin</a> (250 to 500 mg four times per day) are first-line systemic treatments [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/9,14\" class=\"abstract_t\">9,14</a>]. (See <a href=\"topic.htm?path=penicillin-antistaphylococcal-penicillins-and-broad-spectrum-penicillins\" class=\"medical medical_review\">&quot;Penicillin, antistaphylococcal penicillins, and broad-spectrum penicillins&quot;</a>.)</p><p/><p class=\"bulletIndent1\">However, if MRSA is cultured or suspected, the patient should be treated with a 7- to 10-day course of oral <a href=\"topic.htm?path=trimethoprim-drug-information\" class=\"drug drug_general\">trimethoprim</a><span class=\"nowrap\">/sulfamethoxazole</span> (1 to 2 DS tablets twice daily), <a href=\"topic.htm?path=clindamycin-drug-information\" class=\"drug drug_general\">clindamycin</a> (300 to 450 mg four times per day), or <a href=\"topic.htm?path=doxycycline-drug-information\" class=\"drug drug_general\">doxycycline</a> (100 mg twice daily). Occasionally, treatment for more than two weeks is required for resolution of MRSA folliculitis [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/1\" class=\"abstract_t\">1</a>]. (See <a href=\"topic.htm?path=methicillin-resistant-staphylococcus-aureus-mrsa-in-adults-treatment-of-skin-and-soft-tissue-infections\" class=\"medical medical_review\">&quot;Methicillin-resistant Staphylococcus aureus (MRSA) in adults: Treatment of skin and soft tissue infections&quot;</a>.)</p><p/><p class=\"bulletIndent1\">Another treatment that may be effective for staphylococcal folliculitis is topical <a href=\"topic.htm?path=retapamulin-drug-information\" class=\"drug drug_general\">retapamulin</a> ointment, an agent used for the treatment of impetigo [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/15\" class=\"abstract_t\">15</a>].</p><p/><p class=\"bulletIndent1\">In our experience, staphylococcal folliculitis, particularly of the scalp or trunk, is sometimes persistent or recurrent despite treatment. There are insufficient data for definitive conclusions on the best approach to refractory staphylococcal folliculitis. In clinical practice, these patients are often given extended courses of oral antibiotics (eg, up to three months). Measures to prevent recurrences may also be implemented.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Prevention </strong>&ndash; The best approach to the prevention of recurrence has not been established. Avoidance of predisposing factors for folliculitis (eg, occlusive clothing, hyperhidrosis) may be beneficial. A decolonization regimen, such as a five-day course of topical <a href=\"topic.htm?path=mupirocin-drug-information\" class=\"drug drug_general\">mupirocin</a> ointment in the nares and daily <a href=\"topic.htm?path=chlorhexidine-gluconate-drug-information\" class=\"drug drug_general\">chlorhexidine</a> body washes plus daily decontamination of personal items (eg, towels, clothing) has been suggested for patients with recurrent abscesses in an attempt to reduce recurrences [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/16\" class=\"abstract_t\">16</a>]. However, more data are indicated to confirm efficacy of such measures for recurrent staphylococcal folliculitis. <a href=\"topic.htm?path=benzoyl-peroxide-drug-information\" class=\"drug drug_general\">Benzoyl peroxide</a> washes and bleach baths have also been used in attempts to reduce recurrences of staphylococcal folliculitis.</p><p/><p class=\"headingAnchor\" id=\"H19981454\"><span class=\"h3\">Gram-negative folliculitis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Gram-negative folliculitis due to <em>Pseudomonas </em>is often self-limiting and resolves within 7 to 10 days with just good skin hygiene. Avoidance of contaminated water and proper chlorination of pools and hot tubs is preventative. Oral <a href=\"topic.htm?path=ciprofloxacin-drug-information\" class=\"drug drug_general\">ciprofloxacin</a> (250 to 750 mg twice daily) can be used for severe cases or immunocompromised patients [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/8\" class=\"abstract_t\">8</a>].</p><p>Selection of an antibiotic for gram-negative folliculitis due to long-term systemic antibiotic therapy should be guided by testing to determine antibiotic sensitivity of the causative organism. <a href=\"topic.htm?path=ampicillin-drug-information\" class=\"drug drug_general\">Ampicillin</a> (250 to 500 mg four times daily), <a href=\"topic.htm?path=trimethoprim-drug-information\" class=\"drug drug_general\">trimethoprim</a><span class=\"nowrap\">/sulfamethoxazole</span> (1 DS tablet twice daily), or <a href=\"topic.htm?path=ciprofloxacin-drug-information\" class=\"drug drug_general\">ciprofloxacin</a> (250 to 750 mg twice daily) are common first-line treatments. Treatment with these agents is for an additional 14 days after clinical resolution [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/9\" class=\"abstract_t\">9</a>]. Oral <a href=\"topic.htm?path=isotretinoin-drug-information\" class=\"drug drug_general\">isotretinoin</a> (0.5 to 1 <span class=\"nowrap\">mg/kg</span> daily for four to five months) is the treatment of choice for recalcitrant disease [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/17\" class=\"abstract_t\">17</a>].</p><p class=\"headingAnchor\" id=\"H604478886\"><span class=\"h1\">FUNGAL FOLLICULITIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>After <em>S. aureus</em>, fungi are the most commonly detected microorganisms in folliculitis. The recognition of fungal folliculitis is important because treatment differs from that of bacterial folliculitis [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/18\" class=\"abstract_t\">18</a>].</p><p class=\"headingAnchor\" id=\"H1548859899\"><span class=\"h2\">Etiology and risk factors</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>Malassezia</em> species, dermatophytes, and <em>Candida albicans</em> can cause fungal folliculitis.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong><em>Malassezia </em></strong><strong>(</strong><strong><em>Pityrosporum</em></strong><strong>) folliculitis </strong>&ndash; Multiple species of <em>Malassezia</em>, lipophilic yeasts present in the normal cutaneous flora, cause folliculitis. The most common species are <em>M. globosa, M. sympodialis, M. furfur, </em>and <em>M. restricta </em>[<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/19\" class=\"abstract_t\">19</a>]<em>. </em>These fungi were previously classified under the genus <em>Pityrosporum (P. orbiculare, P. ovale, and P. pachydermatis)</em>, contributing to the alternative name &quot;<em>Pityrosporum </em>folliculitis&quot; [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/20\" class=\"abstract_t\">20</a>].</p><p/><p class=\"bulletIndent1\"><em>Malassezia </em>folliculitis is more common in males than in females. It is also most likely to occur in adolescents and among individuals in hot, humid climates. In a review of 44 patients with <em>Malassezia </em>folliculitis in Japan, 75 percent reported onset during the summer months [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/21\" class=\"abstract_t\">21</a>]. High sebum production in adolescents and increased sweating are both predisposing factors for <em>Malassezia</em> folliculitis [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/19\" class=\"abstract_t\">19</a>]. Other predisposing factors include topical or oral antibiotic use, topical or oral corticosteroid treatment, and immunosuppression [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/21-25\" class=\"abstract_t\">21-25</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Dermatophyte folliculitis </strong>&ndash; <em>Trichophyton, Epidermophyton, </em>and <em>Microsporum </em>species are the usual causes of dermatophyte folliculitis. Tinea capitis (dermatophyte infection of the scalp) and tinea barbae (dermatophyte infection of the beard or mustache areas) are classic forms of dermatophyte infection involving hair follicles. Dermatophyte folliculitis can also occur as a secondary feature of tinea corporis, tinea cruris, and tinea pedis. (See <a href=\"topic.htm?path=dermatophyte-tinea-infections\" class=\"medical medical_review\">&quot;Dermatophyte (tinea) infections&quot;</a>.)</p><p/><p class=\"bulletIndent1\">Majocchi's granuloma is a clinical subtype of dermatophyte folliculitis occurring on sites other than the scalp and beard. Majocchi's granuloma is characterized by deep follicular and dermal involvement and is commonly caused by <em>T. rubrum</em> [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/8\" class=\"abstract_t\">8</a>]. Predisposing factors include shaving of the legs, topical corticosteroid use, and immunocompromised status [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/26\" class=\"abstract_t\">26</a>]. (See <a href=\"topic.htm?path=dermatophyte-tinea-infections#H31\" class=\"medical medical_review\">&quot;Dermatophyte (tinea) infections&quot;, section on 'Majocchi's granuloma'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong><em>Candida</em></strong><strong> folliculitis </strong>&ndash; Cutaneous<strong> </strong><em>C. albicans</em> infection may cause fungal folliculitis. <em>Candida</em> folliculitis has occurred in association with candidemia in intravenous drug users but may also occur in healthy individuals [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/8\" class=\"abstract_t\">8</a>].</p><p/><p class=\"headingAnchor\" id=\"H604478898\"><span class=\"h2\">Clinical manifestations</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>Malassezia</em> folliculitis presents with pruritic, monomorphic, follicular papules or pustules on the chest, back, <span class=\"nowrap\">and/or</span> shoulders (<a href=\"image.htm?imageKey=DERM%2F86998%7EDERM%2F86997\" class=\"graphic graphic_picture graphicRef86998 graphicRef86997 \">picture 15A-B</a>). Less frequent sites of involvement include the face, neck, and extensor side of the arms. In patients with facial involvement, the central face is usually spared with involvement of the forehead, chin, and sides of the face [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/19\" class=\"abstract_t\">19</a>].</p><p>Dermatophyte folliculitis often manifests as follicular pustules surrounded by an erythematous plaque (<a href=\"image.htm?imageKey=DERM%2F86999%7EDERM%2F87000%7EDERM%2F103535%7EDERM%2F103536\" class=\"graphic graphic_picture graphicRef86999 graphicRef87000 graphicRef103535 graphicRef103536 \">picture 16A-D</a>). Associated features vary depending on the location of the infection. The most common presentation of Majocchi's granuloma is a unilateral eruption on the lower extremity (<a href=\"image.htm?imageKey=DERM%2F103535%7EDERM%2F103536\" class=\"graphic graphic_picture graphicRef103535 graphicRef103536 \">picture 16C-D</a>). The upper extremities, specifically the forearm and dorsal hand, are additional common locations. Hair loss is common and the inflammation can be suppurative and granulomatous, depending on the depth of infection [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/8\" class=\"abstract_t\">8</a>]. (See <a href=\"topic.htm?path=dermatophyte-tinea-infections#H31\" class=\"medical medical_review\">&quot;Dermatophyte (tinea) infections&quot;, section on 'Majocchi's granuloma'</a>.)</p><p><em>Candida</em> folliculitis has been described as a widely distributed pustular folliculitis [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/8\" class=\"abstract_t\">8</a>]. Less common sites of involvement are the face (beard or mustache area) and scalp [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/27\" class=\"abstract_t\">27</a>]. In rare cases, <em>Candida</em> folliculitis mimics tinea barbae, manifesting as a fluctuant plaque on the face with follicular pustules and papules [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/28\" class=\"abstract_t\">28</a>].</p><p class=\"headingAnchor\" id=\"H604478904\"><span class=\"h2\">Diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>To confirm fungal folliculitis, a potassium hydroxide (KOH) examination can be performed on skin scrapings from an involved area. Hyphae suggest a dermatophyte folliculitis (<a href=\"image.htm?imageKey=DERM%2F100246\" class=\"graphic graphic_picture graphicRef100246 \">picture 17</a>) [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/26\" class=\"abstract_t\">26</a>], whereas yeast cells and pseudohyphae suggest <em>Candida</em> infection (<a href=\"image.htm?imageKey=DERM%2F64872\" class=\"graphic graphic_picture graphicRef64872 \">picture 18</a>) [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/28\" class=\"abstract_t\">28</a>]. Budding spores and short, curved hyphae are suggestive of <em>Malassezia </em>species. (See <a href=\"topic.htm?path=office-based-dermatologic-diagnostic-procedures#H4044416\" class=\"medical medical_review\">&quot;Office-based dermatologic diagnostic procedures&quot;, section on 'Potassium hydroxide preparation'</a>.)</p><p>Although a standard KOH preparation is usually sufficient, a commercial or compounded KOH solution mixed with ink can facilitate visualization of hyphae and spores. In addition, a study that included 49 patients with <em>Malassezia </em>folliculitis found that staining skin scrapings with a May-Gr&uuml;nwald-Giemsa stain was more effective than a KOH preparation in detecting <em>Malassezia</em> [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/19\" class=\"abstract_t\">19</a>].</p><p>Fungal cultures can identify dermatophyte or candidal infections; however, the results are not available immediately. Cultures for <em>Malassezia</em> are not routinely performed because <em>Malassezia</em> is difficult to culture without specialized media.</p><p>A skin biopsy usually is not necessary to diagnose fungal folliculitis. If performed, a biopsy may reveal yeast or hyphae in hair follicles (<a href=\"image.htm?imageKey=DERM%2F103502%7EDERM%2F103503\" class=\"graphic graphic_picture graphicRef103502 graphicRef103503 \">picture 19A-B</a>). A periodic acid-Schiff (PAS) stain may be performed to highlight fungal elements [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/29\" class=\"abstract_t\">29</a>]. <em>Malassezia</em> can be seen in normal hair follicles; therefore, clinical correlation is important.</p><p class=\"headingAnchor\" id=\"H604478910\"><span class=\"h2\">Differential diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The differential diagnosis for fungal folliculitis is similar to the differential diagnosis of bacterial folliculitis. (See <a href=\"#H604478874\" class=\"local\">'Differential diagnosis'</a> above.)</p><p class=\"headingAnchor\" id=\"H604478916\"><span class=\"h2\">Treatment</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The approach to the treatment of fungal folliculitis depends on the etiology. Oral antifungal agents such as <a href=\"topic.htm?path=fluconazole-drug-information\" class=\"drug drug_general\">fluconazole</a> and <a href=\"topic.htm?path=itraconazole-drug-information\" class=\"drug drug_general\">itraconazole</a> are common treatments. Oral <a href=\"topic.htm?path=ketoconazole-drug-information\" class=\"drug drug_general\">ketoconazole</a> should <strong>not</strong> be used for the treatment of any form of fungal folliculitis due to risks of liver injury, adrenal gland disorders, and significant drug interactions [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/30\" class=\"abstract_t\">30</a>].</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong><em>Malassezia</em></strong><strong> folliculitis </strong>&ndash;<strong> </strong>Both systemic and topical antifungal therapies have been used for <em>Malassezia</em> folliculitis. Systemic therapy is often considered more effective than topical treatment based upon the concept that systemic therapy may eliminate <em>Malassezia</em> deep within hair follicles [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/30\" class=\"abstract_t\">30</a>]. However, randomized trials comparing systemic and topical therapy are lacking. </p><p/><p class=\"bulletIndent1\">Benefit from <a href=\"topic.htm?path=itraconazole-drug-information\" class=\"drug drug_general\">itraconazole</a> (200 mg taken orally daily for one week) was demonstrated in a randomized trial that compared itraconazole (200 mg per day for seven days) to placebo in 26 patients with <em>Malassezia</em> folliculitis. After five weeks, 9 of 13 patients in the itraconazole group had no visual evidence of disease and 11 of 13 had a negative KOH preparation, whereas none of 12 patients in the placebo group had complete clearance of disease and only 1 of 12 had negative KOH preparation [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/31\" class=\"abstract_t\">31</a>].</p><p/><p class=\"bulletIndent1\">Despite the greater evidence for efficacy of <a href=\"topic.htm?path=itraconazole-drug-information\" class=\"drug drug_general\">itraconazole</a>, we most often treat with oral <a href=\"topic.htm?path=fluconazole-drug-information\" class=\"drug drug_general\">fluconazole</a> based upon the drug's more favorable side effect profile and lower risk for drug interactions. Fluconazole can be given as 100 to 200 mg daily for one to four weeks or 300 mg once weekly for one to two months [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/30\" class=\"abstract_t\">30</a>].</p><p/><p class=\"bulletIndent1\">Data on the efficacy of topical agents as primary treatments are limited. A retrospective study in which 44 patients with <em>Malassezia</em> folliculitis were treated with either twice-daily application of <a href=\"topic.htm?path=ketoconazole-drug-information\" class=\"drug drug_general\">ketoconazole</a> 2% cream (37 patients) or 100 mg per day of oral <a href=\"topic.htm?path=itraconazole-drug-information\" class=\"drug drug_general\">itraconazole</a> (7 patients), both given until papules flattened, found that all patients in both groups reached this endpoint (mean response time of 27&plusmn;16 days versus 14&plusmn;4 days, respectively). In addition, a small uncontrolled study documented benefit of <a href=\"topic.htm?path=selenium-sulfide-drug-information\" class=\"drug drug_general\">selenium sulfide</a> shampoo (applied for 30 minutes for three consecutive days, then once weekly), propylene glycol 50% in water (applied twice daily for three weeks, then twice weekly), or <a href=\"topic.htm?path=econazole-drug-information\" class=\"drug drug_general\">econazole</a> cream (applied nightly for three weeks, then twice weekly) in the majority of treated patients [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/32\" class=\"abstract_t\">32</a>]. However, poor results with econazole solution (applied twice daily for one month) and <a href=\"topic.htm?path=miconazole-drug-information\" class=\"drug drug_general\">miconazole</a> cream (applied twice daily for one month) were documented in another uncontrolled study [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/33\" class=\"abstract_t\">33</a>]. </p><p/><p class=\"bulletIndent1\">Recurrence is common after treatment. Long-term periodic (eg, once- or twice-weekly) use of topical treatments, often <a href=\"topic.htm?path=selenium-sulfide-drug-information\" class=\"drug drug_general\">selenium sulfide</a>, <a href=\"topic.htm?path=ketoconazole-drug-information\" class=\"drug drug_general\">ketoconazole</a>, or <a href=\"topic.htm?path=ciclopirox-drug-information\" class=\"drug drug_general\">ciclopirox</a> shampoos, is often performed in an attempt to prevent recurrence of disease [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/33\" class=\"abstract_t\">33</a>].</p><p/><p class=\"bulletIndent1\">Although not typically indicated, successful treatment of <em>Malassezia </em>folliculitis with <a href=\"topic.htm?path=isotretinoin-drug-information\" class=\"drug drug_general\">isotretinoin</a> and photodynamic therapy have been reported [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/30,34,35\" class=\"abstract_t\">30,34,35</a>]. Oral <a href=\"topic.htm?path=terbinafine-drug-information\" class=\"drug drug_general\">terbinafine</a> is not effective for treating <em>Malassezia.</em></p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Dermatophyte folliculitis </strong>&ndash;<strong> </strong>Dermatophyte folliculitis must be treated with systemic therapy. Topical antifungals can be used to decrease the spread of the disease, but are usually ineffective because they cannot penetrate into the deep hair follicle. We usually manage tinea barbae in adults with a two- to four-week course of <a href=\"topic.htm?path=griseofulvin-drug-information\" class=\"drug drug_general\">griseofulvin</a> microsize (500 mg per day) or oral <a href=\"topic.htm?path=terbinafine-drug-information\" class=\"drug drug_general\">terbinafine</a> (250 mg per day). <a href=\"topic.htm?path=itraconazole-drug-information\" class=\"drug drug_general\">Itraconazole</a> and <a href=\"topic.htm?path=fluconazole-drug-information\" class=\"drug drug_general\">fluconazole</a> are also effective for dermatophyte folliculitis [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/8,26\" class=\"abstract_t\">8,26</a>]. Treatment for Majocchi's granuloma and tinea capitis is reviewed separately. (See <a href=\"topic.htm?path=dermatophyte-tinea-infections#H31\" class=\"medical medical_review\">&quot;Dermatophyte (tinea) infections&quot;, section on 'Majocchi's granuloma'</a> and <a href=\"topic.htm?path=tinea-capitis#H949998314\" class=\"medical medical_review\">&quot;Tinea capitis&quot;, section on 'Treatment'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong><em>Candida </em></strong><strong>folliculitis</strong><strong><em> </em></strong>&ndash;<em> Candida</em> folliculitis can be treated with systemic <a href=\"topic.htm?path=itraconazole-drug-information\" class=\"drug drug_general\">itraconazole</a> or <a href=\"topic.htm?path=fluconazole-drug-information\" class=\"drug drug_general\">fluconazole</a>. Oral <a href=\"topic.htm?path=terbinafine-drug-information\" class=\"drug drug_general\">terbinafine</a> is not effective [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/8,28\" class=\"abstract_t\">8,28</a>].</p><p/><p class=\"headingAnchor\" id=\"H604478922\"><span class=\"h1\">VIRAL FOLLICULITIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Viral folliculitis is most commonly associated with herpesvirus infections. Molluscum contagiosum virus also can cause folliculitis.</p><p class=\"headingAnchor\" id=\"H604478928\"><span class=\"h2\">Etiology and risk factors</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Herpes folliculitis is a rare manifestation of herpesvirus infections. It is most commonly associated with varicella zoster virus (VZV) infection, but also can be attributed to herpes simplex virus (HSV)-1 or HSV-2. HSV is less likely than VZV to target the hair follicle [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/36\" class=\"abstract_t\">36</a>].</p><p>Molluscum contagiosum virus (MCV) is a poxvirus that preferentially affects children and immunocompromised adults, but also occurs in healthy adults. MCV is a rare cause of viral folliculitis [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/37-39\" class=\"abstract_t\">37-39</a>]. (See <a href=\"topic.htm?path=molluscum-contagiosum\" class=\"medical medical_review\">&quot;Molluscum contagiosum&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H604478934\"><span class=\"h2\">Clinical manifestations</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Erythematous papules, pustules, vesicles, papulovesicles, and plaques are the most common presentations of herpes folliculitis [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/36,40\" class=\"abstract_t\">36,40</a>]. These lesions are often grouped or clustered [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/40\" class=\"abstract_t\">40</a>]. HSV folliculitis in the beard area (herpetic sycosis) is reported most commonly in immunocompromised patients, but may also occur in the absence of immunosuppression [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/41,42\" class=\"abstract_t\">41,42</a>].</p><p>Papules and pustules along with characteristic umbilicated papules are typical findings in molluscum folliculitis. Presentations resembling tinea barbae and pseudolymphoma have been reported [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/37,41,42\" class=\"abstract_t\">37,41,42</a>].</p><p class=\"headingAnchor\" id=\"H604478940\"><span class=\"h2\">Diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Folliculitis in a grouped or clustered distribution suggests the possibility of herpes folliculitis. Viral culture, polymerase chain reaction (PCR), or immunofluorescence testing should be performed to confirm the diagnosis if herpes folliculitis is suspected [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/40\" class=\"abstract_t\">40</a>]. A skin biopsy is not usually necessary, but can be performed if the diagnosis is uncertain. Histopathologic examination of viral folliculitis may reveal intranuclear viral inclusions with multinucleated giant cells in and around the follicular epithelium.</p><p>When present in conjunction with folliculitis, the umbilicated papules of molluscum contagiosum suggest MCV as the cause of folliculitis. In cases where the diagnosis is unclear, a skin biopsy will reveal characteristic molluscum bodies (Henderson-Patterson bodies) in the follicular epithelium [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/37\" class=\"abstract_t\">37</a>]. (See <a href=\"topic.htm?path=molluscum-contagiosum#H7\" class=\"medical medical_review\">&quot;Molluscum contagiosum&quot;, section on 'Diagnosis'</a>.)</p><p class=\"headingAnchor\" id=\"H604478946\"><span class=\"h2\">Differential diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The differential diagnosis for viral folliculitis resembles the differential diagnosis for bacterial folliculitis. (See <a href=\"#H604478874\" class=\"local\">'Differential diagnosis'</a> above.)</p><p class=\"headingAnchor\" id=\"H604478952\"><span class=\"h2\">Treatment</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Herpes folliculitis can be treated with 5 to 10 days of oral <a href=\"topic.htm?path=acyclovir-drug-information\" class=\"drug drug_general\">acyclovir</a> (200 mg five times per day), <a href=\"topic.htm?path=valacyclovir-drug-information\" class=\"drug drug_general\">valacyclovir</a> (500 mg three times per day), or <a href=\"topic.htm?path=famciclovir-drug-information\" class=\"drug drug_general\">famciclovir</a> (500 mg three times per day). </p><p>Molluscum folliculitis can be treated similarly to classic molluscum contagiosum infection. Common treatment options for molluscum contagiosum include curettage, <a href=\"topic.htm?path=cantharidin-united-states-not-available-drug-information\" class=\"drug drug_general\">cantharidin</a>, and cryotherapy. Podophyllotoxin and <a href=\"topic.htm?path=trichloroacetic-acid-drug-information\" class=\"drug drug_general\">trichloroacetic acid</a> are additional treatments [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/8\" class=\"abstract_t\">8</a>]. (See <a href=\"topic.htm?path=molluscum-contagiosum#H8\" class=\"medical medical_review\">&quot;Molluscum contagiosum&quot;, section on 'Overview of management'</a>.)</p><p class=\"headingAnchor\" id=\"H604478958\"><span class=\"h1\">DEMODEX FOLLICULITIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>Demodex folliculorum </em>is a mite belonging to the class of arachnids and a proposed cause of facial folliculitis. <em>Demodex </em>mites are also proposed to contribute to the pathogenesis of papulopustular rosacea and chronic blepharitis [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/11,43\" class=\"abstract_t\">11,43</a>].</p><p class=\"headingAnchor\" id=\"H604478964\"><span class=\"h2\">Etiology and risk factors</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The role of <em>D. folliculorum</em> in folliculitis is controversial because the mite is a common inhabitant of the pilosebaceous unit in normal skin. Up to 80 to 90 percent of humans may harbor the <em>Demodex </em>organism<em> </em>[<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/44\" class=\"abstract_t\">44</a>]. Support for a pathogenic role in folliculitis and rosacea stems from improvement in these disorders with anti-<em>Demodex</em> therapies [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/8\" class=\"abstract_t\">8</a>]. In addition, increased density of mites in the skin has been detected in patients with rosacea [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/45\" class=\"abstract_t\">45</a>].</p><p><em>Demodex </em>folliculitis is most frequently diagnosed in adults. However, <em>Demodex</em> folliculitis also has been implicated in facial pustules and papules in children [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/46\" class=\"abstract_t\">46</a>]. Immunosuppression may increase risk for cutaneous manifestations of <em>Demodex</em> infection [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/47\" class=\"abstract_t\">47</a>].</p><p class=\"headingAnchor\" id=\"H604478970\"><span class=\"h2\">Clinical manifestations</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>Demodex</em> folliculitis is usually characterized by rosacea-like inflammatory papules and pustules on the face [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/44\" class=\"abstract_t\">44</a>]. In addition, authors have described nodulocystic and conglobate (abscess-like) presentations [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/48\" class=\"abstract_t\">48</a>].</p><p class=\"headingAnchor\" id=\"H604478976\"><span class=\"h2\">Diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>Demodex</em> folliculitis is often first suspected when patients with a rosacea-like papulopustular eruption fail to respond to antibiotic therapy for rosacea. A potassium hydroxide (KOH) preparation of a skin scraping from an involved area is typically used to detect <em>Demodex</em> mites. Clinical correlation is necessary for the interpretation of the KOH preparation because <em>Demodex</em> mites can be detected in normal skin and a definitive threshold for diagnosis has not been established. In general, the KOH preparation may be considered positive when more than a few mites are detected [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/44\" class=\"abstract_t\">44</a>]. Although not typically performed in clinical practice, more than five mites per cm<sup>2</sup> detected on an adhesive skin-surface biopsy utilizing a cyanoacrylic adhesive has been proposed as a threshold for use in clinical studies [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/49\" class=\"abstract_t\">49</a>].</p><p><em>Demodex</em> mites may also be detected on skin biopsy. As with a KOH preparation, visualization of <em>Demodex</em> is not sufficient to confirm the diagnosis in the absence of clinical correlation because <em>Demodex</em> mites can be present in follicles in normal skin.</p><p class=\"headingAnchor\" id=\"H604478982\"><span class=\"h2\">Differential diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The differential diagnosis for <em>Demodex </em>folliculitis is similar to the differential diagnosis of facial bacterial folliculitis. (See <a href=\"#H604478874\" class=\"local\">'Differential diagnosis'</a> above.)</p><p class=\"headingAnchor\" id=\"H604478988\"><span class=\"h2\">Treatment</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Data on treatment options for <em>Demodex</em> folliculitis are limited. Topical <a href=\"topic.htm?path=permethrin-drug-information\" class=\"drug drug_general\">permethrin</a> 5% cream, topical sulfur, oral <a href=\"topic.htm?path=ivermectin-drug-information\" class=\"drug drug_general\">ivermectin</a>, and oral <a href=\"topic.htm?path=metronidazole-drug-information\" class=\"drug drug_general\">metronidazole</a> are reasonable treatments [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/45\" class=\"abstract_t\">45</a>]. The findings of one randomized trial suggest that combination therapy with oral ivermectin and oral metronidazole is more effective for reducing mite counts than oral ivermectin monotherapy [<a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/43\" class=\"abstract_t\">43</a>]; however, further study is necessary to confirm whether combination therapy is indicated for <em>Demodex</em> folliculitis. The efficacy of topical ivermectin remains to be determined.</p><p>We typically treat with <a href=\"topic.htm?path=permethrin-drug-information\" class=\"drug drug_general\">permethrin</a> 5% cream or oral <a href=\"topic.htm?path=ivermectin-drug-information\" class=\"drug drug_general\">ivermectin</a>. Topical permethrin can be applied to the entire face before bed and washed off after 8 to 14 hours. Oral ivermectin can be given as two 200 <span class=\"nowrap\">mcg/kg</span> doses separated by one week.</p><p class=\"headingAnchor\" id=\"H1230511060\"><span class=\"h1\">SOCIETY GUIDELINE LINKS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See <a href=\"topic.htm?path=society-guideline-links-skin-and-soft-tissue-infections\" class=\"medical medical_society_guidelines\">&quot;Society guideline links: Skin and soft tissue infections&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H604478994\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Folliculitis is inflammation of the superficial or deep portion of the hair follicle. Folliculitis may be infectious or noninfectious. Infectious folliculitis can be caused by bacteria, fungi, viruses, or parasites. The most common pathogen in infectious folliculitis is <em>Staphylococcus aureus. </em>Other common pathogens are <em>Pseudomonas aeruginosa</em>, <em>Malassezia</em> species, and <em>Demodex </em>mites. (See <a href=\"#H604478843\" class=\"local\">'Introduction'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Follicular pustules and follicular erythematous papules are the most common clinical findings of folliculitis. (See <a href=\"#H604478849\" class=\"local\">'Bacterial folliculitis'</a> above and <a href=\"#H604478886\" class=\"local\">'Fungal folliculitis'</a> above and <a href=\"#H604478922\" class=\"local\">'Viral folliculitis'</a> above and <a href=\"#H604478958\" class=\"local\">'Demodex folliculitis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A diagnosis of folliculitis often can be made based upon the patient history and clinical findings. Further testing is necessary when the etiology is unclear. A Gram stain, bacterial culture, potassium hydroxide (KOH) preparation, viral culture, polymerase chain reaction assay, or immunofluorescence testing can aid in diagnosis. Skin biopsies are not usually necessary, but may be helpful in difficult cases. (See <a href=\"#H604478849\" class=\"local\">'Bacterial folliculitis'</a> above and <a href=\"#H604478886\" class=\"local\">'Fungal folliculitis'</a> above and <a href=\"#H604478922\" class=\"local\">'Viral folliculitis'</a> above and <a href=\"#H604478958\" class=\"local\">'Demodex folliculitis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The management of folliculitis varies based upon the etiology. Mild <em>S. aureus</em> folliculitis may resolve without medical treatment. For patients with known or suspected <em>S. aureus</em> folliculitis that persists and involves a limited area of skin, we suggest topical antibiotic therapy rather than oral antibiotic therapy as initial treatment (<a href=\"grade.htm?i=6\" class=\"grade\">Grade 2C</a>). Topical <a href=\"topic.htm?path=mupirocin-drug-information\" class=\"drug drug_general\">mupirocin</a> and topical <a href=\"topic.htm?path=clindamycin-drug-information\" class=\"drug drug_general\">clindamycin</a> are our preferred initial treatments. (See <a href=\"#H19981424\" class=\"local\">'Staphylococcal folliculitis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>For patients with more extensive <em>S. aureus</em> folliculitis or <em>S. aureus</em> folliculitis that fails to resolve or recurs after topical treatment, we suggest systemic antibiotic therapy rather than topical antibiotic therapy (<a href=\"grade.htm?i=6\" class=\"grade\">Grade 2C</a>). Appropriate initial treatment options include <a href=\"topic.htm?path=dicloxacillin-drug-information\" class=\"drug drug_general\">dicloxacillin</a> and <a href=\"topic.htm?path=cephalexin-drug-information\" class=\"drug drug_general\">cephalexin</a>. If methicillin-resistant <em>S. aureus</em> is suspected, patients should be treated with <a href=\"topic.htm?path=trimethoprim-drug-information\" class=\"drug drug_general\">trimethoprim</a><span class=\"nowrap\">/sulfamethoxazole,</span> <a href=\"topic.htm?path=clindamycin-drug-information\" class=\"drug drug_general\">clindamycin</a>, or <a href=\"topic.htm?path=doxycycline-drug-information\" class=\"drug drug_general\">doxycycline</a>. (See <a href=\"#H19981424\" class=\"local\">'Staphylococcal folliculitis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Oral antifungal therapy is the mainstay of therapy for fungal folliculitis. Antiparasitic agents, such as <a href=\"topic.htm?path=permethrin-drug-information\" class=\"drug drug_general\">permethrin</a> and oral <a href=\"topic.htm?path=ivermectin-drug-information\" class=\"drug drug_general\">ivermectin</a>, can be effective for <em>Demodex</em> folliculitis. (See <a href=\"#H604478886\" class=\"local\">'Fungal folliculitis'</a> above and <a href=\"#H604478958\" class=\"local\">'Demodex folliculitis'</a> above.)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/1\" class=\"nounderline abstract_t\">Cohen PR. Community-acquired methicillin-resistant Staphylococcus aureus skin infections: implications for patients and practitioners. Am J Clin Dermatol 2007; 8:259.</a></li><li><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/2\" class=\"nounderline abstract_t\">Yu Y, Cheng AS, Wang L, et al. Hot tub folliculitis or hot hand-foot syndrome caused by Pseudomonas aeruginosa. J Am Acad Dermatol 2007; 57:596.</a></li><li><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/3\" class=\"nounderline abstract_t\">Teraki Y, Nakamura K. Rubbing skin with nylon towels as a major cause of pseudomonas folliculitis in a Japanese population. J Dermatol 2015; 42:81.</a></li><li><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/4\" class=\"nounderline abstract_t\">Mazza J, Borkin M, Buchholz R, Deleo V. Pseudomonas folliculitis contracted from rubber gloves: a public health concern. J Am Acad Dermatol 2013; 69:e93.</a></li><li><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/5\" class=\"nounderline abstract_t\">Kitamura M, Kawai S, Horio T. Pseudomonas aeruginosa folliculitis: a sporadic case from use of a contaminated sponge. Br J Dermatol 1998; 139:359.</a></li><li><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/6\" class=\"nounderline abstract_t\">Neubert U, Jansen T, Plewig G. Bacteriologic and immunologic aspects of gram-negative folliculitis: a study of 46 patients. Int J Dermatol 1999; 38:270.</a></li><li><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/7\" class=\"nounderline abstract_t\">Juli&agrave; Manresa M, Vicente Villa A, Gen&eacute; Giralt A, Gonz&aacute;lez-Ense&ntilde;at MA. Aeromonas hydrophila folliculitis associated with an inflatable swimming pool: mimicking Pseudomonas aeruginosa infection. Pediatr Dermatol 2009; 26:601.</a></li><li><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/8\" class=\"nounderline abstract_t\">Luelmo-Aguilar J, Santandreu MS. Folliculitis: recognition and management. Am J Clin Dermatol 2004; 5:301.</a></li><li><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/9\" class=\"nounderline abstract_t\">Laureano AC, Schwartz RA, Cohen PJ. Facial bacterial infections: folliculitis. Clin Dermatol 2014; 32:711.</a></li><li><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/10\" class=\"nounderline abstract_t\">Chiller K, Selkin BA, Murakawa GJ. Skin microflora and bacterial infections of the skin. J Investig Dermatol Symp Proc 2001; 6:170.</a></li><li><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/11\" class=\"nounderline abstract_t\">Dessinioti C, Antoniou C, Katsambas A. Acneiform eruptions. Clin Dermatol 2014; 32:24.</a></li><li><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/12\" class=\"nounderline abstract_t\">Lopez FA, Lartchenko S. Skin and soft tissue infections. Infect Dis Clin North Am 2006; 20:759.</a></li><li><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/13\" class=\"nounderline abstract_t\">Williamson DA, Monecke S, Heffernan H, et al. High usage of topical fusidic acid and rapid clonal expansion of fusidic acid-resistant Staphylococcus aureus: a cautionary tale. Clin Infect Dis 2014; 59:1451.</a></li><li><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/14\" class=\"nounderline abstract_t\">van Bijnen EM, Paget WJ, den Heijer CD, et al. Primary care treatment guidelines for skin infections in Europe: congruence with antimicrobial resistance found in commensal Staphylococcus aureus in the community. BMC Fam Pract 2014; 15:175.</a></li><li><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/15\" class=\"nounderline abstract_t\">Bohaty BR, Choi S, Cai C, Hebert AA. Clinical and bacteriological efficacy of twice daily topical retapamulin ointment 1% in the management of impetigo and other uncomplicated superficial skin infections. Int J Womens Dermatol 2015; 1:13.</a></li><li><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/16\" class=\"nounderline abstract_t\">Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis 2014; 59:e10.</a></li><li><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/17\" class=\"nounderline abstract_t\">B&ouml;ni R, Nehrhoff B. Treatment of gram-negative folliculitis in patients with acne. Am J Clin Dermatol 2003; 4:273.</a></li><li><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/18\" class=\"nounderline abstract_t\">Jahns AC, Lundskog B, Berg J, et al. Microbiology of folliculitis: a histological study of 39 cases. APMIS 2014; 122:25.</a></li><li><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/19\" class=\"nounderline abstract_t\">Durdu M, G&uuml;ran M, Ilkit M. Epidemiological characteristics of Malassezia folliculitis and use of the May-Gr&uuml;nwald-Giemsa stain to diagnose the infection. Diagn Microbiol Infect Dis 2013; 76:450.</a></li><li><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/20\" class=\"nounderline abstract_t\">Pedrosa AF, Lisboa C, Gon&ccedil;alves Rodrigues A. Malassezia infections: a medical conundrum. J Am Acad Dermatol 2014; 71:170.</a></li><li><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/21\" class=\"nounderline abstract_t\">Suzuki C, Hase M, Shimoyama H, Sei Y. Treatment Outcomes for Malassezia Folliculitis in theDermatology Department of a University Hospital in Japan. Med Mycol J 2016; 57:E63.</a></li><li><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/22\" class=\"nounderline abstract_t\">Rubenstein RM, Malerich SA. Malassezia (pityrosporum) folliculitis. J Clin Aesthet Dermatol 2014; 7:37.</a></li><li><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/23\" class=\"nounderline abstract_t\">Gaitanis G, Velegraki A, Mayser P, Bassukas ID. Skin diseases associated with Malassezia yeasts: facts and controversies. Clin Dermatol 2013; 31:455.</a></li><li><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/24\" class=\"nounderline abstract_t\">Rhie S, Turcios R, Buckley H, Suh B. Clinical features and treatment of Malassezia folliculitis with fluconazole in orthotopic heart transplant recipients. J Heart Lung Transplant 2000; 19:215.</a></li><li><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/25\" class=\"nounderline abstract_t\">Prindaville B, Belazarian L, Levin NA, Wiss K. Pityrosporum folliculitis: A retrospective review of 110 cases. J Am Acad Dermatol 2018; 78:511.</a></li><li><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/26\" class=\"nounderline abstract_t\">Ilkit M, Durdu M, Karaka&#351; M. Majocchi's granuloma: a symptom complex caused by fungal pathogens. Med Mycol 2012; 50:449.</a></li><li><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/27\" class=\"nounderline abstract_t\">Durdu M, G&uuml;ran M, Kandemir H, et al. Clinical and Laboratory Features of Six Cases of Candida and Dermatophyte Folliculitis and a Review of Published Studies. Mycopathologia 2016; 181:97.</a></li><li><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/28\" class=\"nounderline abstract_t\">Kapda&#287;li H, Ozt&uuml;rk G, Dereli T, et al. Candida folliculitis mimicking tinea barbae. Int J Dermatol 1997; 36:295.</a></li><li><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/29\" class=\"nounderline abstract_t\">Song HS, Kim SK, Kim YC. Comparison between Malassezia Folliculitis and Non-Malassezia Folliculitis. Ann Dermatol 2014; 26:598.</a></li><li><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/30\" class=\"nounderline abstract_t\">Hald M, Arendrup MC, Svejgaard EL, et al. Evidence-based Danish guidelines for the treatment of Malassezia-related skin diseases. Acta Derm Venereol 2015; 95:12.</a></li><li><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/31\" class=\"nounderline abstract_t\">Parsad D, Saini R, Negi KS. Short-term treatment of pityrosporum folliculitis: a double blind placebo-controlled study. J Eur Acad Dermatol Venereol 1998; 11:188.</a></li><li><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/32\" class=\"nounderline abstract_t\">B&auml;ck O, Faergemann J, H&ouml;rnqvist R. Pityrosporum folliculitis: a common disease of the young and middle-aged. J Am Acad Dermatol 1985; 12:56.</a></li><li><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/33\" class=\"nounderline abstract_t\">Abdel-Razek M, Fadaly G, Abdel-Raheim M, al-Morsy F. Pityrosporum (Malassezia) folliculitis in Saudi Arabia--diagnosis and therapeutic trials. Clin Exp Dermatol 1995; 20:406.</a></li><li><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/34\" class=\"nounderline abstract_t\">Lee JW, Lee HI, Kim MN, et al. Topical photodynamic therapy with methyl aminolevulinate may be an alternative therapeutic option for the recalcitrant Malassezia folliculitis. Int J Dermatol 2011; 50:488.</a></li><li><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/35\" class=\"nounderline abstract_t\">Lee JW, Kim BJ, Kim MN. Photodynamic therapy: new treatment for recalcitrant Malassezia folliculitis. Lasers Surg Med 2010; 42:192.</a></li><li><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/36\" class=\"nounderline abstract_t\">Oon HH, Lim KS, Chong WS, Tan SH. Erythematous and edematous eruption of the face. Herpes folliculitis. Int J Dermatol 2010; 49:973.</a></li><li><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/37\" class=\"nounderline abstract_t\">Jang KA, Kim SH, Choi JH, et al. Viral folliculitis on the face. Br J Dermatol 2000; 142:555.</a></li><li><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/38\" class=\"nounderline abstract_t\">Feldmeyer L, Kamarashev J, Boehler A, et al. Molluscum contagiosum folliculitis mimicking tinea barbae in a lung transplant recipient. J Am Acad Dermatol 2010; 63:169.</a></li><li><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/39\" class=\"nounderline abstract_t\">Lee B, Kang HY. Molluscum folliculitis after leg shaving. J Am Acad Dermatol 2004; 51:478.</a></li><li><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/40\" class=\"nounderline abstract_t\">B&ouml;er A, Herder N, Winter K, Falk T. Herpes folliculitis: clinical, histopathological, and molecular pathologic observations. Br J Dermatol 2006; 154:743.</a></li><li><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/41\" class=\"nounderline abstract_t\">Campanelli A, Marazza G, Stucki L, et al. Fulminant herpetic sycosis: atypical presentation of primary herpetic infection. Dermatology 2004; 208:284.</a></li><li><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/42\" class=\"nounderline abstract_t\">Al-Dhafiri SA, Molinari R. Herpetic folliculitis. J Cutan Med Surg 2002; 6:19.</a></li><li><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/43\" class=\"nounderline abstract_t\">Salem DA, El-Shazly A, Nabih N, et al. Evaluation of the efficacy of oral ivermectin in comparison with ivermectin-metronidazole combined therapy in the treatment of ocular and skin lesions of Demodex folliculorum. Int J Infect Dis 2013; 17:e343.</a></li><li><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/44\" class=\"nounderline abstract_t\">Rusiecka-Zi&oacute;&#322;kowska J, Nokiel M, Fleischer M. Demodex - an old pathogen or a new one? Adv Clin Exp Med 2014; 23:295.</a></li><li><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/45\" class=\"nounderline abstract_t\">Elston DM. Demodex mites: facts and controversies. Clin Dermatol 2010; 28:502.</a></li><li><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/46\" class=\"nounderline abstract_t\">Brown M, Hern&aacute;ndez-Mart&iacute;n A, Clement A, et al. Severe demodexfolliculorum-associated oculocutaneous rosacea in a girl successfully treated with ivermectin. JAMA Dermatol 2014; 150:61.</a></li><li><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/47\" class=\"nounderline abstract_t\">Elston CA, Elston DM. Demodex mites. Clin Dermatol 2014; 32:739.</a></li><li><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/48\" class=\"nounderline abstract_t\">Chen W, Plewig G. Human demodicosis: revisit and a proposed classification. Br J Dermatol 2014; 170:1219.</a></li><li><a href=\"https://www.uptodate.com/contents/infectious-folliculitis/abstract/49\" class=\"nounderline abstract_t\">Forton F, Seys B, Marchal JL, Song AM. Demodex folliculorum and topical treatment: acaricidal action evaluated by standardized skin surface biopsy. Br J Dermatol 1998; 138:461.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 103297 Version 9.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H604478994\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H604478843\" id=\"outline-link-H604478843\">INTRODUCTION</a></li><li><a href=\"#H604478849\" id=\"outline-link-H604478849\">BACTERIAL FOLLICULITIS</a><ul><li><a href=\"#H1548859911\" id=\"outline-link-H1548859911\">Etiology and risk factors</a></li><li><a href=\"#H604478862\" id=\"outline-link-H604478862\">Clinical manifestations</a></li><li><a href=\"#H604478868\" id=\"outline-link-H604478868\">Diagnosis</a></li><li><a href=\"#H604478874\" id=\"outline-link-H604478874\">Differential diagnosis</a></li><li><a href=\"#H604478880\" id=\"outline-link-H604478880\">Treatment</a><ul><li><a href=\"#H19981424\" id=\"outline-link-H19981424\">- Staphylococcal folliculitis</a></li><li><a href=\"#H19981454\" id=\"outline-link-H19981454\">- Gram-negative folliculitis</a></li></ul></li></ul></li><li><a href=\"#H604478886\" id=\"outline-link-H604478886\">FUNGAL FOLLICULITIS</a><ul><li><a href=\"#H1548859899\" id=\"outline-link-H1548859899\">Etiology and risk factors</a></li><li><a href=\"#H604478898\" id=\"outline-link-H604478898\">Clinical manifestations</a></li><li><a href=\"#H604478904\" id=\"outline-link-H604478904\">Diagnosis</a></li><li><a href=\"#H604478910\" id=\"outline-link-H604478910\">Differential diagnosis</a></li><li><a href=\"#H604478916\" id=\"outline-link-H604478916\">Treatment</a></li></ul></li><li><a href=\"#H604478922\" id=\"outline-link-H604478922\">VIRAL FOLLICULITIS</a><ul><li><a href=\"#H604478928\" id=\"outline-link-H604478928\">Etiology and risk factors</a></li><li><a href=\"#H604478934\" id=\"outline-link-H604478934\">Clinical manifestations</a></li><li><a href=\"#H604478940\" id=\"outline-link-H604478940\">Diagnosis</a></li><li><a href=\"#H604478946\" id=\"outline-link-H604478946\">Differential diagnosis</a></li><li><a href=\"#H604478952\" id=\"outline-link-H604478952\">Treatment</a></li></ul></li><li><a href=\"#H604478958\" id=\"outline-link-H604478958\">DEMODEX FOLLICULITIS</a><ul><li><a href=\"#H604478964\" id=\"outline-link-H604478964\">Etiology and risk factors</a></li><li><a href=\"#H604478970\" id=\"outline-link-H604478970\">Clinical manifestations</a></li><li><a href=\"#H604478976\" id=\"outline-link-H604478976\">Diagnosis</a></li><li><a href=\"#H604478982\" id=\"outline-link-H604478982\">Differential diagnosis</a></li><li><a href=\"#H604478988\" id=\"outline-link-H604478988\">Treatment</a></li></ul></li><li><a href=\"#H1230511060\" id=\"outline-link-H1230511060\">SOCIETY GUIDELINE LINKS</a></li><li><a href=\"#H604478994\" id=\"outline-link-H604478994\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DERM/103297|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=DERM/103499\" class=\"graphic graphic_picture\">- Staphylococcal folliculitis on chest</a></li><li><a href=\"image.htm?imageKey=DERM/103500\" class=\"graphic graphic_picture\">- Staphylococcal folliculitis close view</a></li><li><a href=\"image.htm?imageKey=DERM/62930\" class=\"graphic graphic_picture\">- Folliculitis in dark skin</a></li><li><a href=\"image.htm?imageKey=DERM/50187\" class=\"graphic graphic_picture\">- Staphylococcal folliculitis on leg</a></li><li><a href=\"image.htm?imageKey=ID/98255\" class=\"graphic graphic_picture\">- Pseudomonas folliculitis</a></li><li><a href=\"image.htm?imageKey=ID/98256\" class=\"graphic graphic_picture\">- Pseudomonas folliculitis scattered papules</a></li><li><a href=\"image.htm?imageKey=DERM/103501\" class=\"graphic graphic_picture\">- Bacterial folliculitis</a></li><li><a href=\"image.htm?imageKey=DERM/70809\" class=\"graphic graphic_picture\">- Inflammatory acne</a></li><li><a href=\"image.htm?imageKey=DERM/67890\" class=\"graphic graphic_picture\">- Rosacea papules</a></li><li><a href=\"image.htm?imageKey=DERM/64577\" class=\"graphic graphic_picture\">- Perioral dermatitis lesions</a></li><li><a href=\"image.htm?imageKey=DERM/97993\" class=\"graphic graphic_picture\">- Acne keloidalis nuchae - mild</a></li><li><a href=\"image.htm?imageKey=PC/69365\" class=\"graphic graphic_picture\">- Pseudofolliculitis barbae 2</a></li><li><a href=\"image.htm?imageKey=DERM/86994\" class=\"graphic graphic_picture\">- Steroid acne 1</a></li><li><a href=\"image.htm?imageKey=DERM/86995\" class=\"graphic graphic_picture\">- Steroid acne 2</a></li><li><a href=\"image.htm?imageKey=PC/55753\" class=\"graphic graphic_picture\">- EGFR inhibitor acneiform erupt</a></li><li><a href=\"image.htm?imageKey=DERM/60786\" class=\"graphic graphic_picture\">- Keratosis pilaris light skin</a></li><li><a href=\"image.htm?imageKey=DERM/90465\" class=\"graphic graphic_picture\">- Hidradenitis suppurativa Hurley stage III</a></li><li><a href=\"image.htm?imageKey=DERM/75169\" class=\"graphic graphic_picture\">- Scabies buttocks</a></li><li><a href=\"image.htm?imageKey=PC/76504\" class=\"graphic graphic_picture\">- Grover's disease</a></li><li><a href=\"image.htm?imageKey=DERM/86998\" class=\"graphic graphic_picture\">- Pityrosporum folliculitis 2</a></li><li><a href=\"image.htm?imageKey=DERM/86997\" class=\"graphic graphic_picture\">- Pityrosporum folliculitis 1</a></li><li><a href=\"image.htm?imageKey=DERM/86999\" class=\"graphic graphic_picture\">- Tinea barbae 1</a></li><li><a href=\"image.htm?imageKey=DERM/87000\" class=\"graphic graphic_picture\">- Tinea barbae 2</a></li><li><a href=\"image.htm?imageKey=DERM/103535\" class=\"graphic graphic_picture\">- Majocchi's granuloma on extremity</a></li><li><a href=\"image.htm?imageKey=DERM/103536\" class=\"graphic graphic_picture\">- Majocchi's granuloma on hand</a></li><li><a href=\"image.htm?imageKey=DERM/100246\" class=\"graphic graphic_picture\">- Dermatophyte infection KOH</a></li><li><a href=\"image.htm?imageKey=DERM/64872\" class=\"graphic graphic_picture\">- Candida pseudohyphae yeast</a></li><li><a href=\"image.htm?imageKey=DERM/103502\" class=\"graphic graphic_picture\">- Dermatophyte folliculitis</a></li><li><a href=\"image.htm?imageKey=DERM/103503\" class=\"graphic graphic_picture\">- Malassezia folliculitis</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=acne-keloidalis-nuchae\" class=\"medical medical_review\">Acne keloidalis nuchae</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=acneiform-eruption-secondary-to-epidermal-growth-factor-receptor-egfr-inhibitors\" class=\"medical medical_review\">Acneiform eruption secondary to epidermal growth factor receptor (EGFR) inhibitors</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=approach-to-the-patient-with-pustular-skin-lesions\" class=\"medical medical_review\">Approach to the patient with pustular skin lesions</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cellulitis-and-skin-abscess-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Cellulitis and skin abscess: Clinical manifestations and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=dermatophyte-tinea-infections\" class=\"medical medical_review\">Dermatophyte (tinea) infections</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=grovers-disease-transient-and-persistent-acantholytic-dermatosis\" class=\"medical medical_review\">Grover's disease (transient and persistent acantholytic dermatosis)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=hiv-associated-eosinophilic-folliculitis\" class=\"medical medical_review\">HIV-associated eosinophilic folliculitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=hidradenitis-suppurativa-pathogenesis-clinical-features-and-diagnosis\" class=\"medical medical_review\">Hidradenitis suppurativa: Pathogenesis, clinical features, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=keratosis-pilaris\" class=\"medical medical_review\">Keratosis pilaris</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=methicillin-resistant-staphylococcus-aureus-mrsa-in-adults-epidemiology\" class=\"medical medical_review\">Methicillin-resistant Staphylococcus aureus (MRSA) in adults: Epidemiology</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=methicillin-resistant-staphylococcus-aureus-mrsa-in-adults-treatment-of-skin-and-soft-tissue-infections\" class=\"medical medical_review\">Methicillin-resistant Staphylococcus aureus (MRSA) in adults: Treatment of skin and soft tissue infections</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=methicillin-resistant-staphylococcus-aureus-infections-in-children-epidemiology-and-clinical-spectrum\" class=\"medical medical_review\">Methicillin-resistant Staphylococcus aureus infections in children: Epidemiology and clinical spectrum</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=molluscum-contagiosum\" class=\"medical medical_review\">Molluscum contagiosum</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=office-based-dermatologic-diagnostic-procedures\" class=\"medical medical_review\">Office-based dermatologic diagnostic procedures</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pathogenesis-clinical-manifestations-and-diagnosis-of-acne-vulgaris\" class=\"medical medical_review\">Pathogenesis, clinical manifestations, and diagnosis of acne vulgaris</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=penicillin-antistaphylococcal-penicillins-and-broad-spectrum-penicillins\" class=\"medical medical_review\">Penicillin, antistaphylococcal penicillins, and broad-spectrum penicillins</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=perioral-periorificial-dermatitis\" class=\"medical medical_review\">Perioral (periorificial) dermatitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pseudofolliculitis-barbae\" class=\"medical medical_review\">Pseudofolliculitis barbae</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pseudomonas-aeruginosa-skin-and-soft-tissue-infections\" class=\"medical medical_review\">Pseudomonas aeruginosa skin and soft tissue infections</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=rosacea-pathogenesis-clinical-features-and-diagnosis\" class=\"medical medical_review\">Rosacea: Pathogenesis, clinical features, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=scabies-epidemiology-clinical-features-and-diagnosis\" class=\"medical medical_review\">Scabies: Epidemiology, clinical features, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=society-guideline-links-skin-and-soft-tissue-infections\" class=\"medical medical_society_guidelines\">Society guideline links: Skin and soft tissue infections</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=tinea-capitis\" class=\"medical medical_review\">Tinea capitis</a></li></ul></div></div>","javascript":null}